Ventricular Catheters Market Report 2026

The ventricular catheters market size has grown strongly in recent years. It will grow from $0.77 billion in 2025 to $0.83 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to rising prevalence of hydrocephalus and neurological disorders, increasing number of traumatic brain injury cases, growing adoption of neurosurgical procedures in hospitals, expansion of neurocritical care infrastructure, increasing awareness of intracranial pressure management.

The ventricular catheters market size is expected to see strong growth in the next few years. It will grow to $1.17 billion by 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to increasing advancements in neuroimaging and neurosurgical technologies, rising demand for minimally invasive neurosurgical devices, growing investment in neurocritical care units, expansion of aging population prone to neurological conditions, increasing adoption of smart and sensor integrated medical devices. Major trends in the forecast period include increasing adoption of antibiotic impregnated ventricular catheters to reduce infection risk in neurosurgical procedures, growing demand for minimally invasive cerebrospinal fluid drainage systems in critical care settings, rising use of smart pressure monitoring ventricular catheters for real-time intracranial pressure tracking, expanding application of advanced biomaterial based catheters for improved biocompatibility and patient outcomes, increasing utilization of pediatric and neonatal specific ventricular access devices in specialized neurology care.

The increasing demand for neurosurgical procedures is expected to propel the growth of the ventricular catheters market going forward. Neurosurgical procedures refer to medical operations conducted on the brain, spinal cord, or nervous system to diagnose, treat, or manage conditions such as tumors, injuries, or neurological disorders. The increasing demand for neurosurgical procedures is driven by the rising prevalence of neurological disorders, as a growing number of patients require surgical intervention for conditions including brain tumors, stroke, and spinal disorders. Ventricular catheters support the growth of neurosurgical procedures by facilitating effective cerebrospinal fluid drainage, intracranial pressure monitoring, and targeted therapeutic interventions in patients with neurological disorders. For instance, in January 2025, according to Great Ormond Street Hospital, brain tumor neurosurgical procedures increased to 126 in April 2023-March 2024, compared to 121 in April 2022-March 2023, indicating a rise in surgical volume. Therefore, the increasing demand for neurosurgical procedures is driving the growth of the ventricular catheters market.

Leading companies operating in the ventricular catheters market are concentrating on developing innovative solutions, such as advanced flow-regulated external ventricular drain (EVD) systems, to improve cerebrospinal fluid drainage efficiency, minimize catheter blockage and infection risks, and enhance intracranial pressure management along with overall patient outcomes. Advanced flow-regulated external ventricular drain (EVD) systems are neurosurgical devices designed to automatically regulate and maintain consistent cerebrospinal fluid drainage from the brain’s ventricles, helping manage intracranial pressure more safely and effectively compared to traditional gravity-based systems. For instance, in March 2025, Anuncia Medical Inc., a US-based medical device company, obtained approval from the U. S. Food and Drug Administration (FDA) for ReFlow External Ventricular Drain (EVD), an innovative ventricular catheter system developed to improve CSF management in patients requiring temporary cerebrospinal fluid diversion. This system incorporates a proprietary flow-control mechanism intended to minimize catheter obstruction and support consistent CSF drainage without the need for frequent manual intervention. It is designed to deliver more stable intracranial pressure management, potentially reducing the risk of complications linked with conventional external ventricular drainage systems.

In June 2023, Luciole Medical AG acquired Spiegelberg GmbH & Co. KG for an undisclosed amount. Through this acquisition, Luciole Medical aims to broaden its neurotechnology portfolio by incorporating cerebrospinal fluid drainage and intracranial pressure monitoring products, thereby strengthening its capabilities in comprehensive brain monitoring solutions. Spiegelberg GmbH & Co. KG is a Germany-based manufacturer of ventricular drainage catheters used for cerebrospinal fluid (CSF) drainage in conditions such as hydrocephalus, traumatic brain injury, and subarachnoid hemorrhage.

Major companies operating in the ventricular catheters market are Medtronic plc, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, FUJIFILM Corporation, Teleflex Incorporated, Biotronik Se And Co. Kg, Integra LifeSciences Holdings Corporation, Merit Medical Systems Inc., Lepu Medical Technology (Beijing) Co Ltd., Natus Medical Incorporated, MicroPort NeuroTech Co Ltd., Raumedic Ag, Sophysa SAS, Neuromedex GmbH, Anuncia Medical Inc., DESU Medical, Dispomedica GmbH, Luciole Medical AG, Surgiwear Limited.

North America was the largest region in the ventricular catheters market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the ventricular catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ventricular catheters market consists of sales of antibiotic-impregnated ventricular catheters, silver-coated ventricular catheters, neonatal ventricular catheters, pediatric ventricular catheters, magnetic resonance imaging-compatible ventricular catheters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.